“Safety and Efficacy of Tacrolimus Ointment 0.03 % as a Steroid-Sparing Regimen in Patients with Severe or Refractory Vernal Keratoconjunctivitis (VKC): A study from Quetta, Balochistan”, J Fatima Jinnah Med Univ, vol. 20, no. 2, pp. 99–104, Aug. 2026, doi: 10.37018/ONBQ9330.